Indaptus Therapeutics Market Risk Adjusted Performance
| INDP Stock | | | USD 1.78 0.08 4.71% |
The Market Risk Adjusted Performance indicator for Indaptus Therapeutics is derived from observed market data. The dataset is based on observed market activity where data is available. Indaptus Therapeutics has a market cap of 3.81 M, current ratio of 9.18.
Risk vs Return Analysis can help frame allocation decisions. Indaptus Therapeutics can be included in a portfolio to evaluate diversification impact. Weighting is typically determined by the allocation framework in use. Broader economic conditions can influence Indaptus Therapeutics's company valuation — related indicators include
signals in unemployment.
Researching Indaptus Stock? See our
How to Buy Indaptus Therapeutics guide. The guide includes approaches for both long-term investing and shorter-term trading of Indaptus Stock. The guide provides a structured overview of the trading process for Indaptus Therapeutics.
Indaptus Therapeutics has current Market Risk Adjusted Performance of 0.0412.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 0.0412 | |
| ER[a] | = | Expected return on investing in Indaptus Therapeutics |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
Indaptus Therapeutics is ranked
fifth for market risk adjusted performance against industry peers. It is currently under evaluation for maximum drawdown against industry peers with Maximum Drawdown measuring nearly
1,253 against Market Risk Adjusted Performance. Maximum Drawdown runs about
1,253 times Market Risk Adjusted Performance for Indaptus Therapeutics
Other Technical Indicators